Management of cutaneous melanoma.
作者： Hensin Tsao , Michael B. Atkins , Arthur J. Sober
DOI: 10.1056/NEJMRA041245
关键词: Dermatology 、 Cutaneous melanoma 、 Disease 、 Medicine 、 Melanoma diagnosis 、 Secondary prevention 、 Neoplasm staging 、 Treatment options
摘要: Cutaneous melanoma remains a management challenge. This year an estimated 55,000 Americans will receive diagnosis of cutaneous melanoma, and 7900 die from the disease. The authors this review discuss pathogenesis provide perspective on treatment options.
sci-hub.se 参考文章(101)
Michael E. Egger, Charles R. Scoggins, Kelly M. McMasters, The Sunbelt Melanoma Trial. Annals of Surgical Oncology. ,vol. 27, pp. 28- 34 ,(2020) , 10.1245/S10434-019-07828-4
Steven A. Rosenberg, John Rosenberg, Principles and Practice of the Biologic Therapy of Cancer ,(2000)
María S Soengas, Paola Capodieci, David Polsky, Jaume Mora, Manel Esteller, Ximena Opitz-Araya, Richard McCombie, James G Herman, William L Gerald, Yuri A Lazebnik, Carlos Cordón-Cardó, Scott W Lowe, None, Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature. ,vol. 409, pp. 207- 211 ,(2001) , 10.1038/35051606
E. Appella, Y. Kawakami, S. Southwood, S. A. Rosenberg, P. F. Robbins, K. Sakaguchi, A. Sette, S. Eliyahu, C. Jennings, Xiaoqiang Kang, Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. Journal of Immunology. ,vol. 154, pp. 3961- 3968 ,(1995)
Jeffrey E Gershenwald, William Thompson, Paul F Mansfield, Jeffrey E Lee, Maria I Colome, Chi-hong Tseng, J Jack Lee, Charles M Balch, Douglas S Reintgen, Merrick I Ross, None, Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. Journal of Clinical Oncology. ,vol. 17, pp. 976- 983 ,(1999) , 10.1200/JCO.1999.17.3.976
Tom Crosby, Reg Fish, Bernadette Coles, Malcolm Mason, Systemic treatments for metastatic cutaneous melanoma. Cochrane Database of Systematic Reviews. ,vol. 2018, ,(2000) , 10.1002/14651858.CD001215
J M Kirkwood, M H Strawderman, M S Ernstoff, T J Smith, E C Borden, R H Blum, Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. Journal of Clinical Oncology. ,vol. 14, pp. 7- 17 ,(1996) , 10.1200/JCO.1996.14.1.7
U Keilholz, C Conradt, S S Legha, D Khayat, C Scheibenbogen, N Thatcher, S H Goey, M Gore, T Dorval, B Hancock, C J Punt, R Dummer, M F Avril, E B Bröcker, A Benhammouda, A M Eggermont, M Pritsch, Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients. Journal of Clinical Oncology. ,vol. 16, pp. 2921- 2929 ,(1998) , 10.1200/JCO.1998.16.9.2921
Steven A. Rosenberg, James C. Yang, Douglas J. Schwartzentruber, Patrick Hwu, Francesco M. Marincola, Suzanne L. Topalian, Claudia A. Seipp, Jan H. Einhorn, Donald E. White, Seth M. Steinberg, Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b Journal of Clinical Oncology. ,vol. 17, pp. 968- 975 ,(1999) , 10.1200/JCO.1999.17.3.968
P O Livingston, G Y Wong, S Adluri, Y Tao, M Padavan, R Parente, C Hanlon, M J Calves, F Helling, G Ritter, Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. Journal of Clinical Oncology. ,vol. 12, pp. 1036- 1044 ,(1994) , 10.1200/JCO.1994.12.5.1036